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responsibility of XAbstract This study was performed to investigate the possible involvement of polyamines in the
development of cervical cancer. The objective of the present study was therefore to ﬁnd the speciﬁc
polyamine indicators, which could be used as useful markers for the early determination of cervical
cancer. A simple method for the simultaneous determination of plasma concentrations of ﬁve
polyamines in normal and U14 model mice was developed by using HPLC-MS. The samples were
derivatized by benzoyl chloride. The derived polyamines were separated on a C18 column by a
gradient elution with methanol–water, and then detected with HPLC-MS. The results showed that
all polyamine levels in the U14 model mice were higher than those in normal ones. The cadaverine,
putrescine and 1, 3-diaminopropane levels were signiﬁcantly higher in U14 model mice plasma than
those in normal mice plasma, especially the putrescine and 1, 3-diaminopropane (Po0.01). The
cadaverine, putrescine and 1, 3-diaminopropane levels were signiﬁcantly higher in U14 mice model
urine than those in normal mice urine, especially the cadaverine and 1, 3-diaminopropane
(Po0.01). Putrescine, cadaverine and 1, 3-diaminopropane might be the indicators of the cervical
cancer.
& 2012 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.ersity. Production and hosting by E
.008
986296; fax:þ86 24 23986259.
163.com (Q. Wang).
i’an Jiaotong University.1. Introduction
Globally, cervical cancer is the second most common cause of
cancer death in women, with 510,000 estimated new cases and
288,000 deaths annually [1]. Human Papiuomavirus (HPV) is
a necessary cause for invasive cervical cancer worldwide. HPV
DNA is found in 99.7% of all cervical cancer [2]. However,
despite this association, HPV alone is not sufﬁcient to inducelsevier B.V. All rights reserved.
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contact and the incubation period of it was even more than
10 years without any symptoms. Most women who are HPV
positive show no evidence of cervical abnormalities [3] and
only a small proportion of women with HPV develop cervical
cancer [4]. Therefore, ﬁnding more effective indicators to
diagnose the cervical cancer is necessary. Cervical cancer is
preventable and can be cured. The purpose of cervical cancer
screening is the early detection, diagnosis and treatment of
cancer precursor lesions and cancer. Accordingly, searching
out the indicators of cervical cancer has become an important
task for cancer diagnosis and anti-tumor drug monitoring.
Polyamines are endogenous substances and the products of
the cell metabolism. Their metabolites putrescine (PUT), 1,
3-diaminopropane (DAP), cadaverine (CAD), spermidine
(SPD) and spermine (SPM) are the most important in the
regulation of cell growth, differentiation, and synthesis of
proteins and nucleic acids [5–7]. Many papers and reviews on
the relationship between polyamines and cancer have been
substantiated [8–13]. However, most of the literatures only
studied PUT, SPD and SPM. In addition, the changes of ﬁve
different polyamine metabolite levels with the development of
cervical cancer remain undeﬁned. Which polyamine metabo-
lites can be used to diagnose the cervical cancer is not clear.
In the present study, the U14 mice models were established.
Plasma samples were collected at day 2, 4, 8 and 12 after
inoculation. Urine samples were collected at day 5 and 11 after
inoculation. Another normal mice group was used as control.
An HPLC-MS method was applied to determine the concentra-
tions of ﬁve polyamine metabolites in these mice simultaneously.
The relationship between polyamines and cervical cancer was
studied. The aim of this study was to search out the speciﬁc
polyamine indicators of the cervical cancer, which could be used
as useful markers for the early determination of cervical cancer.2. Materials and methods
2.1. Chemicals, reagents and materials
DAP, PUT, SPM, 1, 6-diaminohexane (DAH, used as an
internal standard), CAD hydrochloride, SPD hydrochloride
and benzoyl chloride were obtained from Sigma–Aldrich
(St.Louis, MO, USA). Methanol and acetonitrile of HPLC
grade were purchased from Fisher Chemicals (Fair Lawn, NJ,
USA). All the other reagents were of analytic grade. Distilled
and deionized water was used throughout the experiment.2.2. Animals and cell lines
Female Kunming mice with body weight ranging from 18 to 22 g
were provided by the Experimental Animal Center of Shenyang
Pharmaceutical University (no. 0225336). Animals were bred
under conditions (2272 1C, RH 50720%) with a natural light–
dark cycle for 3 days before the experiment started. All
procedures involving animals were in accordance with the
Regulations of Experimental Animal Administration Issued by
the State Committee of Science and Technology of China.
U14 cervical carcinoma cells were gifted by School of
Pharmacology, Shenyang Pharmaceutical University.2.3. Animal experiments
U14 cervical carcinoma cells were diluted with normal saline
(NS) at a density of 1 108 cells/mL. Kunming mice were
subcutaneously implanted with 1 107 cells/mice on the right
armpit as model group (n¼8). The interval between the ascites
taking and the last mice inoculation was less than 2 h. Another
normal mice group (n¼8) was used as control. Plasma samples
were collected at day 2, 4, 8 and 12 after inoculation. Urine
samples were collected at day 5 and 11 after inoculation. Then
the plasma samples were kept at 20 1C. Urine samples were
centrifuged at 13,000 rpm for 3 min to aid settling of coarse
material. The supernatant liquid was transferred to polypro-
pylene tube and kept at 20 1C. Two mice were combined into
a sample (n¼4) due to the difﬁcult sample collection from mice
except the last plasma collection at day 12 (n¼8). Twelve days
after inoculation, all the mice were sacriﬁced and tumors were
removed and weighted individually.
2.4. Preparation of standard and calibration solutions
Stock solutions for DAP, PUT, CAD, SPD, SPM and DAH
were prepared in methanol at 1 mg/mL. Working standard
solutions were prepared by serial dilution with methanol. All
solutions were stored at 4 1C before analyzed.
Calibration samples at PUT, DAP, CAD, SPD and SPM
concentration of 2.5, 12.5, 25, 125, 250, 500, 1000 ng/mL were
prepared by spiking appropriate amounts of the standard
solution in blank mice plasma.
Calibration samples at DAP, CAD, SPD and SPM con-
centration of 10, 50, 100, 500, 1000, 2000, 4000 ng/ mL, PUT
concentration of 20, 100, 200, 1000, 2000, 4000, 8000 ng/ mL
were prepared by spiking appropriate amounts of the standard
solution in blank mice urine.
2.5. Preparation of plasma and urine samples
Plasma samples (200 mL) were spiked with 50 mL of internal
standard and 120 mL of 10% perchloric acid, then mixed
thoroughly for 3 min and centrifugated at 15,000 rpm for
5 min. The supernatant liquid was transferred to polypropy-
lene tube and submitted to the derivatization procedure.
Urine samples (50 mL) were spiked with 50 mL of internal
standard and 30 mL of 10% perchloric acid, then mixed
thoroughly for 3 min and centrifugated at 15,000 rpm for
5 min. The supernatant liquid was transferred to polypropy-
lene tube and submitted to the derivatization procedure.
2.6. Derivatization procedure
2.6.1. Plasma sample derivatization procedure
Polyamines were derivatized according to the method described
by our research group [14]. To the perchloric supernatants,
620 mL of 2 M NaOH solution, and 250 mL of 4% benzoyl
chloride in acetonitrile were added sequentially. After standing
for 20 min under ultrasonication at 30 1C, excess benzoyl was
removed by mixing with the equal volume of saturated sodium
chloride solution. Polyamine derivatives were extracted into
diethyl ether, followed by evaporating to dryness under
nitrogen. The residue was reconstituted in 100 mL methanol,
and 5 mL of which was injected for HPLC-MS analysis.
Q. Wang et al.222.6.2. Urine sample derivatization procedure
To the perchloric supernatants, 530 mL of 2 M NaOH solution
was added. The remaining processes were the same with the
plasma sample derivatization procedure. The residue was
reconstituted in 100 mL methanol, and 2 mL of which was
injected for HPLC-MS analysis.
2.7. Instrumentation and chromatographic conditions
HPLC-ESI-MS analytical procedures were performed on an
ACQUITY UPLC system coupled to a Quattro Micro API
mass spectrometer (Waters Milford, MA, USA). MassLynx
V4.1 software (Waters) was applied to system operation and
date collection. Derivative polyamines were separated on a
Venusil C18 column (5 mm, 150 mm 4.6 mm i.d.) held at
35 1C. The column was eluted with a gradient mixture of
methanol (phase A) and water (phase B) at the ﬂow rate of
1 mL/min.The gradient program was as follows: 51–54% A
from 0 to 9 min and 54–90% A from 9 to 17 min. A triple
quadrupole tandem mass spectrometer equipped with electro-
spray ionization (ESI) interface was used for analytical detec-
tion. The ESI source was set in positive ionization mode. Target
ions were monitored [MþNa]þ at m/z 305.3 for DAP and cone
at 45 V, [MþNa]þ at m/z 319.4 for PUT and cone at 48 V,
[MþNa]þ at m/z 333.4 for CAD and cone at 50 V, [MþNa]þ at
m/z 347.4 for DAH (I.S.) and cone at 51 V, [MþNa]þ at m/z
480.6 for SPD and cone at 52 V, [MþNa]þ at m/z 641.8 for
SPM and cone at 56 V using the selected ion record (SIR) mode.
The capillary voltage was set at 3500 V, extractor voltage at 2 V,
source temperature at 120 1C and desolvation temperature at
350 1C. Nitrogen was used as the desolvation and cone gas with
a ﬂow rate of 500 and 50 L/h, respectively.
2.8. Validation of the method
2.8.1. Validation of the method of plasma sample
To evaluate linearity, seven calibration solutions were prepared
and assayed together with spiked amount of IS (125 ng/mL) in
triplicate by derivative procedure as described above. The lower
limit of quantiﬁcation (LLOQ) was assessed by determining theTable 1 Validation data for the analysis of polyamines in plasm
Polyamines Calibration range
(ng/mL)
Linearity (r) Calibration equ
PUT 2.5–1000.0 0.9907 y¼4.302 103
DAP 2.5–1000.0 0.9939 y¼7.349 103
CAD 2.5–1000.0 0.9975 y¼6.414 103
SPD 2.5–1000.0 0.9977 y¼1.294 102
SPM 2.5–1000.0 0.9975 y¼3.187 103
Polyamines Intra-day precision (RSD, %)
QC1 QC2 QC3
PUT 8.9 7.3 5.7
DAP 5.8 3.9 5.3
CAD 11.1 1.1 4.0
SPD 7.5 2.7 6.9
SPM 13.2 5.5 4.0concentration of polyamine at 2.5 ng/mL. For intra-day and
inter-day assays, the samples were prepared individually in
triplicate at low (10 ng/mL), medium (125 ng/mL) and high
(400 ng/mL) concentration in methanol. Likewise, the recovery
was determined at three concentrations by comparing the
recovered polyamine concentrations with the nominal concentra-
tions. In order to evaluate the matrix effect on the ionization of
analytes, i.e., the potential ion suppression or enhancement due to
the matrix components, three concentration levels of polyamines
were tested. The matrix effect was evaluated by comparing the
peak area ratio of post-spiked derivative polyamines standards in
the plasma derivatives and IS to that of the neat standard
solutions. The stability of polyamines in mice plasma was studied
under a range of times (0, 2, 4, 8, 12, and 24 h) after derivatiza-
tion. During the analysis, the samples were stored at 4 1C. The
stability of plasma samples was also studied under a range of
times (0, 2 and 4 h) at ambient temperature. The stability of
polyamines in mice plasma was tested for three freeze–thaw
cycles. In each freeze–thaw cycle, the plasma samples were frozen
at 20 1C for 24 h and thawed at room temperature.2.8.2. Validation of the method of urine sample
To evaluate linearity, seven calibration solutions were pre-
pared and assayed together with spiked amount of I.S.
(500 ng/mL) in triplicate by derivative procedure as described
above. The LLOQ was assessed by determining the concentra-
tion of polyamine at 10 ng/mL. For intra-day and inter-day
assays, the samples were prepared individually in triplicate at
low (40 ng/mL, PUT: 80 ng/mL), medium (500 ng/mL, PUT:
1000 ng/mL) and high (1600 ng/mL, PUT: 3200 ng/mL)
concentration in methanol. The remaining processes were the
same with the plasma sample processes.2.9. Data analysis
All data were presented as mean7SD. Signiﬁcances were
analyzed by the t-test for two independent means. po0.05 was
considered signiﬁcant and po0.01 was considered highly sig-
niﬁcant. The SPSS (version 16.0) statistical software was applied.a using the proposed method (n¼3).
ation Plasma recovery (%)
QC1 QC2 QC3 Mean
xþ5.039 102 78.4 90.7 80.4 83.2
xþ2.163 102 83.3 92.5 81.5 85.8
xþ3.857 102 76.1 93.6 90.5 86.7
xþ1.080 101 83.6 84.6 84.9 84.3
xþ7.314 102 75.6 93.3 96.1 88.4
Inter-day precision (RSD, %)
QC1 QC2 QC3
11.6 9.3 9.3
14.2 5.1 11.2
12.4 5.7 7.3
13.7 12.0 12.3
14.0 12.9 10.0
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3.1. Tumor growth
After the tumor cells inoculated, all the Kunming mice were
inoculated successfully, tumorigenicity was 100%. The mean
tumor weight of the U14 model group was 1.3970.44 g at
day 12.
3.2. Method validation
The results of method validation are summarized in Tables 1
and 2 for the plasma sample and Tables 3 and 4 for the urine
sample. The intra-day and inter-day precisions were withinTable 3 Validation data for the analysis of polyamines in urine
Polyamines Calibration range
(ng/mL)
Linearity(r) Calibration equa
PUT 20–8000 0.9979 y¼2.019 102x
DAP 10–4000 0.9940 y¼4.473 103x
CAD 10–4000 0.9928 y¼4.745 103x
SPD 10–4000 0.9940 y¼6.412 102x
SPM 10–4000 0.9959 y¼1.676 103x
Polyamines Intra-day precision (RSD, %)
QC1 QC2 QC3
PUT 11.7 7.7 4.6
DAP 10.0 9.0 9.4
CAD 4.6 12.3 13.6
SPD 5.1 7.7 9.4
SPM 6.4 13.7 8.3
Table 4 Result of stability test of polyamines in urine (n¼3).
Polyamines Post-preparative stability
(RSD, %)
Ur
tem
PUT 6.0 3.8
DAP 7.3 5.5
CAD 5.3 2.1
SPD 11.2 1.4
SPM 10.0 3.8
Table 2 Result of stability test of polyamines in plasma (n¼3).
Polyamines Post-preparative stability
(RSD, %)
Plasma
stability
PUT 8.8 1.9
DAP 3.2 4.1
CAD 6.7 6.9
SPD 7.9 5.2
SPM 14.7 1.614.0% and 15.0%, respectively. Furthermore, the recoveries
ranged from 75.60% to 96.1% for mice plasma and 77.40% to
95.5% for mice urine. In terms of matrix effect, all the ratios
deﬁned in Section 2.8 were between 85.2% and 113.8%, which
meant no signiﬁcant matrix effect in this method. Polyamines
are endogenous substances existing in the blank samples.
Therefore, all values were corrected for polyamine concentra-
tion of the blank mice samples.
3.3. Determination of polyamines in plasma and urine samples
3.3.1. Determination of polyamines in plasma samples
The typical mass chromatograms of polyamines in U14
bearing mice plasma are shown in Fig. 1B. The derivativeusing the proposed method (n¼3).
tion Plasma recovery (%)
QC1 QC2 QC3 Mean
2.336 101 80.6 86.5 87.6 83.2
1.369 102 77.4 83.9 84.2 85.8
4.788 102 82.1 89.9 81.7 86.7
3.163 101 82.4 84.7 95.5 84.3
1.059 102 87.5 81.8 89.5 88.4
Inter-day precision (RSD, %)
QC1 QC2 QC3
7.8 7.8 8.0
7.5 14.6 6.9
7.4 13.2 13.5
9.4 14.1 6.6
4.9 12.9 8.2
ine sample at ambient
perature stability (RSD, %)
Freeze–thaw
stability (RSD, %)
7.9
2.8
7.9
6.6
10.5
sample at ambient temperature
(RSD, %)
Freeze–thaw stability
(RSD, %)
10.8
5.1
6.5
4.0
8.4
Fig. 1 Total ion chromatograms (TIC) obtained from standard polyamines (A), plasma sample (B) and urine sample (C) by HPLC-ESI-MS.
(1) PUT, (2) DAP, (3) CAD, (4) DHA (I.S.), (5) SPD, and (6) SPM.
Q. Wang et al.24polyamines were identiﬁed from the comparison of MS
characteristic of standard polyamines. The mean levels of
each polyamine (nM) are shown in Table 5. Polyamine levels
in the U14 group were compared with those in the normal
group. All of polyamines of model mice were higher than
those of normals. Highly marked increases were found in the
levels of PUT and DAP (po0.01). CAD in the model groupwas signiﬁcantly higher than that in the normal group
(po0.05). However, experimental results showed that the
levels of SPD and SPM were no signiﬁcant difference between
model and normal groups. To classify the model and the
normal mice, PUT, DAP and CAD were analyzed using the
SPSS (version 16.0). The between-groups linkage method was
adopted and squared Euclidean distance was chosen to
Table 5 Amounts of polyamines (nM) in plasma from mice.
Time (day) Group Polyamines (nM) (Mean7SD) Total polyamines
PUT DAP CAD SPD SPM
Second days (n¼4) Normal 1.2770.19 0.1770.04 0.1770.06 2.1070.67 0.3270.05 4.03
U14 1.8770.61 0.1770.03 0.1970.02 1.7170.52 0.3970.04 4.33
Differences þ0.60 0.00 þ0.02 0.39 þ0.07 þ0.30
Fourth days (n¼4) Normal 1.5270.15 0.1670.02 0.1470.01 3.8070.38 0.4370.04 6.05
U14 1.5970.13 0.2070.04 0.4670.63 2.5170.48 0.4370.05 5.20
Differences þ0.07 þ0.04 þ0.32 1.29 0.00 0.85
Eighth days (n¼4) Normal 1.3570.24 0.1870.03 0.1470.02 2.8570.67 0.3670.07 4.88
U14 1.9670.73 0.2770.04 0.1870.04 2.9870.51 0.3870.05 5.78
Differences þ0.61 þ0.09 þ0.04 þ0.13 þ0.02 þ0.90
Twelfth days (n¼8) Normal 1.0970.08 0.1470.03 0.1770.06 2.8770.49 0.3870.09 4.64
U14 2.0070.43 0.2170.07 0.2670.07 3.4770.99 0.4470.18 6.39
Differences þ0.91 þ0.07 þ0.09 þ0.60 þ0.06 þ1.75
nCompared with normal group po0.05.
nnCompared with normal group po0.01.
Fig. 2 Result of the cluster analysis from mice plasma samples,
the Between-groups linkage method was adopted and squared
Euclidean distance was chosen as measurement. Sixteen samples
were clustered into two groups, i.e. Group I and Group II. Bar¼5
rescaled distance.
Study on changes of polyamine levels in mice with the development of U14 cervical cancer 25evaluate the similarity of samples. As displayed in Fig. 2, 16
samples were gathered into two groups, the samples of
normals were classiﬁed in Group I and U14 model mice were
classiﬁed in Group II.3.3.2. Determination of polyamines in urine samples
The typical mass chromatograms of polyamines in U14
bearing mice urine are shown in Fig. 1C. The derivative
polyamines were identiﬁed from the comparison of MS
characteristic of standard polyamines. All values were cor-
rected for the concentration of creatinine in the same urine.
Creatinine was all excreted in the urine without any absorp-
tion. The excretion of creatinine was relatively constant with-
out effects by the amount of urine. As shown in Table 6, the
mean levels of each polyamine (nM of creatinine) of U14
models were higher than those of normals. At day 5, the levels
of DAP and CAD were signiﬁcant difference between model
and normal groups (po0.05). At day 11, highly marked
increases were found in the levels of DAP and CAD
(po0.01). PUT and SPD in the model group were signiﬁcantlyhigher than those in normals (po0.05). PUT, DAP, CAD,
SPD and SPM were analyzed using the SPSS (version 16.0).
The results are shown in Fig. 3. Urine samples were gathered
into two groups, the samples of normals were classiﬁed in
Group I and U14 model mice were classiﬁed in Group II.4. Discussion
Nowadays, in order to get valuable data for rapidly qualitative
and quantitative assessment of anti-tumor activity, many
different tumor models have been established to test the
activity of anti-tumor drugs in vivo [15]. These transplantation
tumors grow rapidly in vivo with short experimental cycle.
The tumor models can be established successfully in 7 to 10
day [16]. Therefore, the last mice samples were collected at
day 12.
PUT, DAP, CAD, SPD and SPM are the metabolic
products of ornithine and lysine. As shown in Fig. 4, PUT is
the precursor of SPD and SPM, and formed by direct
decarboxylation of L-ornithine by Ornithine decarboxylase
(ODC) [17]. DAP is catalyzed by S-adenosylmethionine
decarboxylase (SAMDC). CAD is synthesized by a direct
decarboxylation of lysine by lysine decarboxylase. Our results
showed that the levels of PUT, DAP and CAD were
signiﬁcantly higher in U14 mice than those in normals.
It could be concluded the high activity of ODC, SAMDC
and lysine decarboxylase in the cervical cancer. The inhibitors
of ODC, SAMDC and lysine decarboxylase may be designed
to develop anticancer drugs for cervical cancer.
Compared to cervical cancer, the Hepatoma-22 (H22)
bearing mice models were established in our previous research.
PUT and CAD were signiﬁcantly higher in H22 mice than
those in normals. However, beside PUT and CAD, DAP was
signiﬁcantly increased (po0.01) in cervical cancer mice. There-
fore, it might be concluded that DAP was the speciﬁc
polyamine indicators of the cervical cancer, which could be
one means to classify the cervical cancer and the hepatoma.
Our results showed that SPD decreased in the early stage of
the tumor growth, but then increased rapidly. It could suggest
Fig. 3 Result of the cluster analysis from mice urine samples, the
Between-groups linkage method was adopted and squared Eucli-
dean distance was chosen as measurement. Eight samples were
clustered into two groups, i.e. Group I and Group II. Bar¼5
rescaled distance.
Fig. 4 The possible metabolic process of polyamines. ODC, Orni-
thine decarboxylase, SAMDC, S-adenosylmethionine decarboxylase.
Table 6 Amounts of polyamines (nM of creatinine) in urine from mice.
Time (day) Group Polyamines (nM of creatinine) (Mean7SD) Total polyamines
PUT DAP CAD SPD SPM
Fifth days (n¼4) Normal 74.69716.54 6.6672.70 6.6172.20 5.9873.58 0.3370.16 94.30
U14 125.80748.30 12.0171.96 16.1677.11 7.6573.02 0.5070.37 162.10
Differences þ51.08 þ5.35 þ9.55 þ1.67 þ0.17 þ67.83
Eleventh days (n¼4) Normal 97.90717.60 9.5471.75 12.8876.39 14.6975.66 1.2570.53 136.20
U14 224.60783.20 43.55715.33 53.89719.12 47.93724.95 5.7175.28 394.60
Differences þ126.80 þ34.01 þ41.01 þ33.24 þ4.46 þ257.80
nCompared with normal group po0.05.
nnCompared with normal group po0.01.
Q. Wang et al.26that polyamines have a different metabolic pattern in the
cervical cancer mice. This discrepancy may be due to the
transient suppression of spermidine synthase activity in the
early stage of cervical cancer. With the cervical cancer
development, the activity of spermidine synthase was gradu-
ally increased. Furthermore, the increase value of SPD in
urine samples at day 11 was 19.9 times than that at day 5. The
increase value of SPD in plasma samples at day 12 was 4.6
times than that at day 8. What’s more, many literatures
reported that SPD was increased signiﬁcantly in cervical
cancer patients [18,19]. Therefore, we speculated that SPDlevels could be increased signiﬁcantly with the development of
cervical cancer. As shown in Table 5, in the early stage of
cervical cancer, DAP and CAD were increased more rapidly
than the others. It was suggested that the activity of SAMDC
and lysine decarboxylase was activated ﬁrstly after inocula-
tion. With the development of cervical cancer, PUT, SPD and
SPM were increased, especially PUT and SPD. It could be
inferred that the activity of ODC and spermidine synthase was
activated at this period. Therefore, SAMDC and lysine
decarboxylase might be the targets of the anti-cancer drugs
in the early stage of cervical cancer, while ODC and spermi-
dine synthase in the medi-terminal stage of cervical cancer.
Further studies are required to determine whether enzyme
levels are constitutively linked. Our data showed that poly-
amines which were increased signiﬁcantly in plasma were
consistent with those obtained in urine. In clinic, the urine
samples were easier to collect than the plasma samples.
Therefore, monitoring polyamine levels in urine might play
an important role in diagnosing the cervical cancer.5. Conclusion
DAP was the speciﬁc polyamine indicators of the cervical
cancer, which could be one means to classify the cervical
cancer and the hepatoma. Our ﬁndings conﬁrmed that poly-
amines were useful biochemical markers of cervical cancer.
PUT, CAD and DAP might be used to diagnose the cervical
cancer.Acknowledgments
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